Michael C. Kaufmann, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 20,576 shares at $72.06 ($1.5M) on 2014-08-18, disclosed to the SEC on 2014-08-19.
Scheduled sale ($1.5M) by CEO, Pharmaceutical Segment under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.13 | 13,743 | $991K | 66.8% |
| 2 | $72.06 | 6,833 | $492K | 33.2% |
| Total | $72.11 avg | 20,576 | $1.5M | 100% |
| Filing → |
| CAH | SELL | 2013-05-23 | $2K | — | Filing → |
| CAH | SELL | 2013-01-25 | $2.6M | — | Filing → |
| CAH | SELL | 2011-10-28 | $1.9M | — | Filing → |